Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 92,038
  • Shares Outstanding, K 97,169
  • Annual Sales, $ 12,890 K
  • Annual Income, $ -40,720 K
  • EBIT $ -40 M
  • EBITDA $ -39 M
  • 60-Month Beta 1.08
  • Price/Sales 6.99
  • Price/Cash Flow N/A
  • Price/Book 2.98
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.49
  • Most Recent Earnings $-0.11 on 11/13/25
  • Next Earnings Date 03/16/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Options Overview Details

View History
  • Implied Volatility 465.34% (-58.39%)
  • Historical Volatility 83.48%
  • IV Percentile 74%
  • IV Rank 26.13%
  • IV High 1,431.48% on 04/14/25
  • IV Low 123.51% on 08/26/25
  • Expected Move (DTE 2) 1.3175 (139.09%)
  • Put/Call Vol Ratio 0.12
  • Today's Volume 29
  • Volume Avg (30-Day) 110
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 4,959
  • Open Int (30-Day) 4,556
  • Expected Range 0.0000 to 2.2647

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +11.44%
on 12/03/25
1.1864 -20.16%
on 11/17/25
-0.2028 (-17.63%)
since 11/14/25
3-Month
0.8500 +11.44%
on 12/03/25
2.2200 -57.33%
on 10/15/25
-0.4628 (-32.82%)
since 09/16/25
52-Week
0.5327 +77.81%
on 05/23/25
2.2200 -57.33%
on 10/15/25
-0.0128 (-1.33%)
since 12/16/24

Most Recent Stories

More News
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, enhancing...

HYPR : 0.9472 (+2.10%)
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 0.9472 (+2.10%)
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Expansion of initiatives with AI-powered portable MRI will enable evaluation of childhood brain development through neonatal scanning and guide targeted health interventions in underserved communities,...

HYPR : 0.9472 (+2.10%)
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the...

HYPR : 0.9472 (+2.10%)
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 0.9472 (+2.10%)
Hyperfine Reports Strong Q3 2025 Revenue Growth

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

HYPR : 0.9472 (+2.10%)
Hyperfine Announces Pricing of $17.5 Million Public Offering

Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has priced its previously announced underwritten public offering of 14,000,000 shares of the Company’s Class A...

HYPR : 0.9472 (+2.10%)
Hyperfine Announces Proposed Public Offering

Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock...

HYPR : 0.9472 (+2.10%)
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 0.9472 (+2.10%)
Hyperfine Swoop® System Referenced in France’s Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

UniHA approves framework agreement covering over 1,500 French public hospitals, facilitating the purchase of Swoop® AI-powered portable MRI systems over three years

HYPR : 0.9472 (+2.10%)

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 1.0681
2nd Resistance Point 1.0291
1st Resistance Point 0.9881
Last Price 0.9472
1st Support Level 0.9081
2nd Support Level 0.8691
3rd Support Level 0.8281

See More

52-Week High 2.2200
Fibonacci 61.8% 1.5755
Fibonacci 50% 1.3764
Fibonacci 38.2% 1.1772
Last Price 0.9472
52-Week Low 0.5327

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar